Abstract
Abstract The UK National Health Service is paying for next-generation clinical tumor screening at the Oxford University Hospitals NHS Trust, a key step toward making the technology broadly available throughout the country.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
